Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction
Language English Country United States Media print
Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
- Keywords
- arrhythmias, catheter ablation, myocardial infarction, ventricular fibrillation,
- MeSH
- Survival Analysis MeSH
- Ventricular Fibrillation etiology mortality physiopathology therapy MeSH
- Myocardial Infarction complications MeSH
- Catheter Ablation methods MeSH
- Ventricular Premature Complexes complications physiopathology therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Hospital Mortality MeSH
- Follow-Up Studies MeSH
- Proportional Hazards Models MeSH
- Purkinje Fibers physiopathology MeSH
- Recurrence MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Stroke Volume MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Observational Study MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Ventricular fibrillation (VF) storm after myocardial infarction (MI) is a life-threatening condition that necessitates multiple defibrillations. Catheter ablation is a potentially effective treatment strategy for VF storm refractory to optimal medical treatment. However, its impact on patient survival has not been verified in a large population. METHODS: We conducted a multicenter, retrospective observational study involving consecutive patients who underwent catheter ablation of post-MI refractory VF storm without preceding monomorphic ventricular tachycardia. The target of ablation was the Purkinje-related ventricular extrasystoles triggering VF. The primary outcome was in-hospital and long-term mortalities. Univariate logistic regression and Cox proportional-hazards analysis were used to evaluate clinical characteristics associated with in-hospital and long-term mortalities, respectively. RESULTS: One hundred ten patients were enrolled (age, 65±11years; 92 men; left ventricular ejection fraction, 31±10%). VF storm occurred at the acute phase of MI (4.5±2.5 days after the onset of MI during the index hospitalization for MI) in 43 patients (39%), the subacute phase (>1 week) in 48 (44%), and the remote phase (>6 months) in 19 (17%). The focal triggers were found to originate from the scar border zone in 88 patients (80%). During in-hospital stay after ablation, VF storm subsided in 92 patients (84%). Overall, 30 (27%) in-hospital deaths occurred. The duration from the VF occurrence to the ablation procedure was associated with in-hospital mortality (odds ratio for each 1-day increase, 1.11 [95% CI, 1.03-1.20]; P=0.008). During follow-up after discharge from hospital, only 1 patient developed recurrent VF storm. However, 29 patients (36%) died, with a median survival time of 2.2 years (interquartile range, 1.2-5.5 years). Long-term mortality was associated with left ventricular ejection fraction <30% (hazard ratio, 2.54 [95% CI, 1.21-5.32]; P=0.014), New York Heart Association class ≥III (hazard ratio, 2.68 [95% CI, 1.16-6.19]; P=0.021), a history of atrial fibrillation (hazard ratio, 3.89 [95% CI, 1.42-10.67]; P=0.008), and chronic kidney disease (hazard ratio, 2.74 [95% CI, 1.15-6.49]; P=0.023). CONCLUSIONS: In patients with MI presenting with focally triggered VF storm, catheter ablation of culprit triggers is lifesaving and appears to be associated with short- and long-term freedom from recurrent VF storm. Mortality over the long-term follow-up is associated with the severity of underlying cardiovascular disease and comorbidities in this specific patient population.
Cardiovascular Division Ibaraki Prefectural Central Hospital Kasama Japan
Department of Cardiology Faculty of Medicine University of Tsukuba Japan
Department of Cardiology Mito Saiseikai General Hospital Japan
Department of Cardiology St Luke's International Hospital Tokyo Japan
Department of Cardiology Tokyo Metropolitan Hiroo Hospital Japan
Department of Cardiovascular Medicine Faculty of Medical Sciences Kyushu University Fukuoka Japan
Department of Cardiovascular Medicine Nippon Medical School Tokyo Japan
Department of Heart Rhythm Management Yokohama Rosai Hospital Japan
Division of Cardiology Showa University School of Medicine Tokyo Japan
Division of Cardiology Tsukuba Memorial Hospital Japan
Hospital Rangueil Centre Hospitalier Universitaire Toulouse France
Institut Hospitalo Universitaire
Institute for Clinical and Experimental Medicine Prague Czech Republic
University Bordeaux Centre de Recherche Cardio thoracique de Bordeaux France
References provided by Crossref.org